D. Klaassen

发表

Eastern Cooperative Oncology Group phase II studies in advanced measurable colorectal cancer. I. Razoxane, Yoshi-864, piperazinedione, and lomustine.

D. V. Von Hoff, P. Engstrom, J. Macintyre, 1985, Cancer treatment reports.

External beam pelvic radiotherapy plus intraperitoneal radioactive chronic phosphate in early stage ovarian cancer: a toxic combination. A National Cancer Institute of Canada Clinical Trials Group Report.

D. Boyes, D. Klaassen, A. Gerulath, 1985, International journal of radiation oncology, biology, physics.

Chemotherapy of advanced colorectal carcinoma: Fluorouracil alone vs. two drug combinations using fluorouracil, hydroxyurea, semustine, dacarbazine, razoxane, and mitomycin A phase III trial by the Eastern Cooperative Oncology Group (EST 1278)

P. Engstrom, A. Mittelman, D. Klaassen, 1984, American journal of clinical oncology.

Specific active immunochemotherapy in lung cancer: a survival study.

J. Harris, D. Klaassen, T. Stewart, 1977, Canadian journal of surgery. Journal canadien de chirurgie.

Lower prevalence of positive atopic skin tests in lung cancer patients.

D. Cockcroft, J. Dosman, H. McDuffie, 1988, Chest.

Screening for Colorectal Cancer in British Columbia

R. Parson, G. Hislop, A. Coldman, 2007 .

Determinants of cell type in patients with cancer of the lungs.

J. Dosman, H. McDuffie, D. Klaassen, 1990, Chest.

Characteristics of patients with primary lung cancer diagnosed at age of 50 years or younger.

J. Dosman, H. McDuffie, D. Klaassen, 1989, Chest.

Combination v. sequential therapy with melphalan, 5-fluorouracil and methotrexate for advanced ovarian cancer.

M. E. Kirk, A. Miller, C. Wall, 1980, Canadian Medical Association journal.

Acute leukemia long‐term survival

K. E. Barrett, D. Klaassen, O. Choi, 1972, Cancer.

Inhibition of human breast cancer colony formation by anticalmodulin agents: Trifluoperazine, W-7, and W-13

D. Klaassen, Jiann-Wu Wei, R. A. Hickie, 2004, Cancer Chemotherapy and Pharmacology.

Cations and calmodulin in normal and neoplastic cell growth regulation.

D. Klaassen, J. W. Wei, R. A. Hickie, 1983, Canadian journal of biochemistry and cell biology = Revue canadienne de biochimie et biologie cellulaire.

Comparison of intensive versus moderate chemotherapy of lymphocytic lymphomas. A progress report

S. Pocock, J. Bennett, R. Lenhard, 1976, Cancer.

Lung cancer: Clinical trial of radiotherapy alone vs. Radiotherapy plus cyclophosphamide

D. White, R. McDermot, D. Klaassen, 1972, Cancer.

Early stage ovarian cancer: a randomized clinical trial comparing whole abdominal radiotherapy, melphalan, and intraperitoneal chromic phosphate: a National Cancer Institute of Canada Clinical Trials Group report.

M. E. Kirk, J. Carmichael, D. Boyes, 1988, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

A phase II study of neocarzinostatin (NSC 157365) in malignant hepatoma

P. Carbone, G. Falkson, D. Klaassen, 1980, Cancer Chemotherapy and Pharmacology.

Combination chemo-radiotherapy for residual, recurrent or inoperable carcinoma of the rectum: E.C.O.G. study (EST 3276).

R. Gelber, C. Danjoux, D. Klaassen, 1985, International journal of radiation oncology, biology, physics.

Immunocompetent cells in malignant disease in man. II. Clinical and immunologic correlates in a case of non-Hodgkin's lymphoma.

M. Keaney, Hassan Khaled Hamdy, D. Klaassen, 1978, Canadian Medical Association journal.

Morbidity and mortality associated with intraperitoneal chemotherapy for Pseudomyxoma peritonei.

A. Shah, S. Butterworth, O. Panton, 2002, American journal of surgery.

Streptozocin-doxorubicin, streptozocin-fluorouracil or chlorozotocin in the treatment of advanced islet-cell carcinoma.

S. Lipsitz, R. Hahn, C. Moertel, 1992, The New England journal of medicine.

A controlled evaluation of recent approaches to biochemical modulation or enhancement of 5-fluorouracil therapy in colorectal carcinoma.

T. Fleming, J. Laurie, C. Moertel, 1985, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

IMMUNOCHEMOTHERAPY OF LUNG CANCER *

D. Klaassen, T. Stewart, R. Bélanger, 1976, Annals of the New York Academy of Sciences.

Treatment of locally unresectable cancer of the stomach and pancreas: a randomized comparison of 5-fluorouracil alone with radiation plus concurrent and maintenance 5-fluorouracil--an Eastern Cooperative Oncology Group study.

P. Engstrom, C. Moertel, J. Macintyre, 1985, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Unresectable Adenocarcinoma of the Pancreas

D. Klaassen, 2000, Cancer investigation.

r Unresectable Adenocarcinoma of the Pancreas

D. Klaassen, 2000 .

Survival and response to chemotherapy for advanced colorectal adenocarcinoma. An eastern cooperative oncology group report

P. Lavin, D. Klaassen, A. Mittelman, 1980, Cancer.

An Eastern Cooperative Oncology Group evaluation of combinations of methyl-CCNU, mitomycin C, Adriamycin, and 5-fluorouracil in advanced measurable gastric cancer (EST 2277).

P. Lavin, A. Paul, H. Douglass, 1984, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

A National Cancer Institute of Canada clinical trials group phase II study of eniluracil (776C85) and oral 5-fluorouracil in patients with advanced squamous cell head and neck cancer.

I. Tannock, L. Seymour, M. Knowling, 2001, Annals of oncology : official journal of the European Society for Medical Oncology.

Second primary malignancies following the treatment of early stage ovarian cancer: update of a study by the National Cancer Institute of Canada--Clinical Trials Group (NCIC-CTG).

J. Pater, B. Zee, S. Dent, 2000, Annals of oncology : official journal of the European Society for Medical Oncology.

Men, women and primary lung cancer--a Saskatchewan personal interview study.

J. Dosman, H. McDuffie, D. Klaassen, 1991, Journal of clinical epidemiology.

Female‐male differences in patients with primary lung cancer

J. Dosman, H. McDuffie, D. Klaassen, 1987, Cancer.

Farming and exposure to chemicals in male lung cancer patients and their siblings.

D. Cockcroft, J. Dosman, H. McDuffie, 1988, Journal of occupational medicine. : official publication of the Industrial Medical Association.

Mitomycin C, methyl-CCNU and 5-fluorouracil in the treatment of metastatic colorectal carcinoma

A. Rossof, P. Bonomi, D. Klaassen, 2004, Cancer Chemotherapy and Pharmacology.

Phase II evaluation of mitomycin and cisplatin in advanced esophageal carcinoma.

P. Lavin, P. Engstrom, D. Klaassen, 1983, Cancer treatment reports.

Response to medroxyprogesterone acetate (NSC-26386) as secondary hormone therapy for metastatic breast cancer in postmenopausal women.

D. Klaassen, W. Hirte, E. Rapp, 1976, Cancer treatment reports.

A phase II study of m-AMSA in patients with primary liver cancer

G. Falkson, D. Klaassen, B. Coetzer, 2004, Cancer Chemotherapy and Pharmacology.